Zadno, Rajpal Discuss Leadership Change, New Studies on PiXL
Newly appointed CEO Reza Zadno, PhD, explains why he found Avedro to be such a promising opportunity. Rajesh Rajpal, MD, Chief Medical Officer, discusses two recent studies showing non-surgical photorefractive intrastromal corneal collagen cross-linking, or PiXL, is a promising new treatment for vision improvement for low myopia.
Reza Zadno, PhD
Reza is a serial entrepreneur and investor who joined InterWest in 2012. As a successful ophthalmology and cardiology executive, he has a special interest in medical devices.
Rajesh K. Rajpal, MD
Raj Rajpal, MD is a board certified ophthalmologist who has established an internationally recognized reputation as an expert in the fields of corneal, cataract, and refractive surgery.